|
Verifying Insulin Strategy and Initial Health Outcome Analysi
|
Ongoing
|
N/A
|
4
|
F3Z-MC-B01
|
International Medical Center (Jeddah), King Fahd University Hospital (al khobar), King Fahad Medical (City), Armed Forces Hospital (Taif)
|
|
The Effect of Vitamin D3 on Biomarkers of Glycaemia and Oxidative Stress in Saudi Men with Poorly-Controlled Type 2 Diabetes Mellitus
|
Ongoing
|
Vitamin D Capsules
|
4
|
H-01-R-012
|
King Fahad Medical City (Riyadh)
|
|
(LUMINOUS)Study to observe the effectiveness andsafety of ranibizumab through individualized patienttreatment and associated
|
Ongoing
|
Ranibizumab 10mg/ml (Lucentis)
|
4
|
FB002A2406
|
King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah) , Prince Sultan Military Medical City (Riyadh)
|
|
Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial
|
Ongoing
|
Colistin
|
4
|
CCD-AFM-00
|
King Saud Medical City (Riyadh)
|
|
Dyslipidemia International Study II: Lipid target achievement in high risk patients with Acute Coronary Syndrome (DYSIS II)
|
Ongoing
|
N/A
|
4
|
0653A 427
|
Riyadh Care Hospital (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Glargine Insulin versus Continuous Regular Insulin in Diabetic Surgical Patients Receiving Total Parenteral Nutrition
|
Ongoing
|
Lantus®
|
4
|
147
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A multicenter, observational, prospective Study of theuse of Valsartan (Tabuvan®) and Valsartan HCTZ (co-Tabuvan®) on adult patients with essentialHypertension in Saudi Arabia
|
Ongoing
|
Tabuvan
|
4
|
T-VAHST
|
Prince Sultan Military Medical City (Riyadh)
|
|
Multi-Center Prospective Randomized Controlled Trial of Intracranial Pressure Monitoring in Patients with Severe Traumatic Brain Injury
|
Ongoing
|
N/A
|
4
|
RC11/056
|
King Abdulaziz Medical City NG (Riyadh)
|
|
A randomised blinded placebo controlled trial of hydrocortisone in critically illpatients with septic shock
|
Ongoing
|
HYDROCORTISONE
|
4
|
GI-CCT3722
|
King Fahad Medical City (riyadh), King Khalid University Hospital (Riyadh)
|
|
LUMINOUS™: Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes
|
Ongoing
|
RANIBIZUMAB
|
4
|
RFB002A240
|
king khaled eye specialist hospital (riyadh)
|
